End-stage heart failure, in cardiac ultrasound, reveals profound structural and functional abnormalities. Key findings often include severe ventricular dilation, markedly reduced ejection fraction, significant wall motion abnormalities, and valvular regurgitation. Ultrasound helps assess chamber size, wall thickness, and contractility, guiding management and prognosis.
Sonographic indicators of end-stage heart failure also encompass increased filling pressures, evidence of pulmonary hypertension, and often, pericardial effusions. These detailed cardiac ultrasound assessments are crucial for monitoring disease progression, evaluating the effectiveness of therapies, and informing decisions regarding advanced interventions or palliative care in medical practice.
